Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (42)
Joshua S. Friedman, Tomi Jun, Omid Rashidipour, Kuan-lin Huang, Ethan Ellis, Priyanka Kadaba, Puneet Belani, Kambiz Nael, Nadejda M. Tsankova, Robert Sebra & Adília Hormigo. (2023) Using EGFR amplification to stratify recurrent glioblastoma treated with immune checkpoint inhibitors. Cancer Immunology, Immunotherapy 72:6, pages 1893-1901.
Crossref
Crossref
Aleksandrs Krigers, Matthias Demetz, Patrizia Moser, Johannes Kerschbaumer, Konstantin R. Brawanski, Helga Fritsch, Claudius Thomé & Christian F. Freyschlag. (2023) Impact of GAP-43, Cx43 and actin expression on the outcome and overall survival in diffuse and anaplastic gliomas. Scientific Reports 13:1.
Crossref
Crossref
Mrinmay Kumar Mallik, Kaushik Majumdar & Shiraz Mujtaba. (2023) Non-Association of Driver Alterations in PTEN with Differential Gene Expression and Gene Methylation in IDH1 Wildtype Glioblastomas. Brain Sciences 13:2, pages 186.
Crossref
Crossref
Nayuta Higa, Toshiaki Akahane, Taiji Hamada, Hajime Yonezawa, Hiroyuki Uchida, Ryutaro Makino, Shoji Watanabe, Tomoko Takajo, Seiya Yokoyama, Mari Kirishima, Kei Matsuo, Shingo Fujio, Ryosuke Hanaya, Akihide Tanimoto & Koji Yoshimoto. (2022)
Distribution and favorable prognostic implication of genomic
EGFR
alterations in
IDH
‐wildtype glioblastoma
. Cancer Medicine 12:1, pages 49-60.
Crossref
Crossref
Nusaibah Azman, Anani Aila Mat Zin, Sharifah Emilia Tuan Sharif & Ikmal Hisyam Bakrin. (2022) Detection of Isocitrate Dehydrogenase (IDH-1), Epidermal Growth Factor Receptor (EGFR), P53 and C-erbB2/HER2 Mutation in Glial Tumour. Malaysian Journal of Medicine and Health Sciences 18:s21, pages 111-119.
Crossref
Crossref
Bharati Mehani, Saleembhasha Asanigari, Hye-Jung Chung, Karen Dazelle, Arashdeep Singh, Sridhar Hannenhalli & Kenneth Aldape. (2022) Immune cell gene expression signatures in diffuse glioma are associated with IDH mutation status, patient outcome and malignant cell state, and highlight the importance of specific cell subsets in glioma biology. Acta Neuropathologica Communications 10:1.
Crossref
Crossref
Eric J. Hsu, Jamie Thomas, Elizabeth A. Maher, Michael Youssef, Robert D. Timmerman, Zabi Wardak, Tu D. Dan, Toral R. Patel & Dat T. Vo. (2022) Impact of CDKN2A/B, MTAP, and TERT Genetic Alterations on Survival in IDH Wild Type Glioblastomas. Discover Oncology 13:1.
Crossref
Crossref
Peng Zhao, Ningyan Zhang & Zhiqiang An. (2022) Engineering antibody and protein therapeutics to cross the blood–brain barrier. Antibody Therapeutics 5:4, pages 311-331.
Crossref
Crossref
R. Dumke, C. Dumke, F. Eberle, Ch. Nimsky, U. Keber, R. Engenhart-Cabillic & S. Lautenschläger. (2022) Monocentric evaluation of Ki-67 labeling index in combination with a modified RPA score as a prognostic factor for survival in IDH-wildtype glioblastoma patients treated with radiochemotherapy. Strahlentherapie und Onkologie 198:10, pages 892-906.
Crossref
Crossref
Heena Sareen, Yafeng Ma, Therese M. Becker, Tara L. Roberts, Paul de Souza & Branka Powter. (2022) Molecular Biomarkers in Glioblastoma: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences 23:16, pages 8835.
Crossref
Crossref
Giulia Mazzaschi, Alessandro Olivari, Antonio Pavarani, Costanza Anna Maria Lagrasta, Caterina Frati, Denise Madeddu, Bruno Lorusso, Silvia Dallasta, Chiara Tommasi, Antonino Musolino, Marcello Tiseo, Maria Michiara, Federico Quaini & Pellegrino Crafa. (2022) Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma. Cancers 14:13, pages 3249.
Crossref
Crossref
Oluwakanyinsolami Netufo, Kate Connor, Liam P. Shiels, Kieron J. Sweeney, Dan Wu, Donal F. O’Shea, Annette T. Byrne & Ian S. Miller. (2022) Refining Glioblastoma Surgery through the Use of Intra-Operative Fluorescence Imaging Agents. Pharmaceuticals 15:5, pages 550.
Crossref
Crossref
Anna Maria Buccoliero, Laura Giunti, Selene Moscardi, Francesca Castiglione, Aldesia Provenzano, Iacopo Sardi, Mirko Scagnet, Lorenzo Genitori & Chiara Caporalini. (2022) Pediatric High Grade Glioma Classification Criteria and Molecular Features of a Case Series. Genes 13:4, pages 624.
Crossref
Crossref
Felix Corr, Dustin Grimm, Benjamin Saß, Mirza Pojskić, Jörg W. Bartsch, Barbara Carl, Christopher Nimsky & Miriam H. A. Bopp. (2022) Radiogenomic Predictors of Recurrence in Glioblastoma—A Systematic Review. Journal of Personalized Medicine 12:3, pages 402.
Crossref
Crossref
Syed Muhammad Adnan Ali, Muhammad Shahzad Shamim, Syed Ather Enam, Zubair Ahmad, Yumna Adnan & Hasnain Ahmed Farooqui. (2022) Immunohistochemical Detection and Prognostic Significance of p53, Epidermal Growth Factor Receptor, Murine Double Minute 2, and Isocitrate Dehydrogenase 1 in Glioblastoma Multiforme Patients of Pakistan. Clinical Medicine Insights: Oncology 16, pages 117955492211191.
Crossref
Crossref
Hua-fu Zhao, Xiu-ming Zhou, Jing Wang, Fan-fan Chen, Chang-peng Wu, Peng-yu Diao, Lin-rong Cai, Lei Chen, Yan-wen Xu, Jing Liu, Zong-yang Li, Wen-lan Liu, Zhong-ping Chen, Guo-dong Huang & Wei-ping Li. (2021) Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients. Journal of Translational Medicine 19:1.
Crossref
Crossref
Stefanie Moritz, Matthias Krause, Jessica Schlatter, Nils Cordes & Anne Vehlow. (2021) Lamellipodin-RICTOR Signaling Mediates Glioblastoma Cell Invasion and Radiosensitivity Downstream of EGFR. Cancers 13:21, pages 5337.
Crossref
Crossref
Malik Galijašević, Ruth Steiger, Ivan Radović, Anna Maria Birkl-Toeglhofer, Christoph Birkl, Lukas Deeg, Stephanie Mangesius, Andreas Rietzler, Milovan Regodić, Guenther Stockhammer, Christian Franz Freyschlag, Johannes Kerschbaumer, Johannes Haybaeck, Astrid Ellen Grams & Elke Ruth Gizewski. (2021) Phosphorous Magnetic Resonance Spectroscopy and Molecular Markers in IDH1 Wild Type Glioblastoma. Cancers 13:14, pages 3569.
Crossref
Crossref
I.A. Popov, A.I. Shikhlyarova, G.V. Zhukova, Y.Y. Arapova, E.M. Frantsiyants, M.A. Engibaryan, I.V. Kaplieva, E.E. Rostorguev, L.Y. Rozenko, D.Y. Iozefi & M.A. Gusareva. (2021) Hemodynamic and adaptive correlates of transcranial magnetotherapy in patients with high-grade malignant brain gliomas in the early postsurgery period. CARDIOMETRY:18, pages 149-155.
Crossref
Crossref
Kesavan R. Arya, Ramachandran P. Bharath Chand, Chandran S. Abhinand, Achuthsankar S. Nair, Oommen V. Oommen & Perumana R. Sudhakaran. (2021) Identification of Hub Genes and Key Pathways Associated with Anti-VEGF Resistant Glioblastoma Using Gene Expression Data Analysis. Biomolecules 11:3, pages 403.
Crossref
Crossref
Hong-My Nguyen, Kirsten Guz-Montgomery, Devin B. Lowe & Dipongkor Saha. (2021) Pathogenetic Features and Current Management of Glioblastoma. Cancers 13:4, pages 856.
Crossref
Crossref
Manali Tilak, Jennifer Holborn, Laura A. New, Jasmin Lalonde & Nina Jones. (2021) Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme. International Journal of Molecular Sciences 22:4, pages 1831.
Crossref
Crossref
Bin Xu, Jie Mei, Wei Ji, Zhengyuan Huo, Zheng Bian, Jiantong Jiao, Xiaoqing Li, Jun Sun & Junfei Shao. (2021) MicroRNAs involved in the EGFR pathway in glioblastoma. Biomedicine & Pharmacotherapy 134, pages 111115.
Crossref
Crossref
Iyad Alnahhas, Appaji Rayi, Maria del Pilar Guillermo Prieto Eibl, Shirley Ong, Pierre Giglio & Vinay Puduvalli. (2021)
Prognostic implications of epidermal and platelet-derived growth factor receptor alterations in 2 cohorts of IDH
wt
glioblastoma
. Neuro-Oncology Advances 3:1.
Crossref
Crossref
Hyunjong Lee, Minseok Suh, Hongyoon Choi, Seunggyun Ha, Jin Chul Paeng, Gi Jeong Cheon, Keon Wook Kang & Dong Soo Lee. (2020) A pan-cancer analysis of the clinical and genetic portraits of somatostatin receptor expressing tumor as a potential target of peptide receptor imaging and therapy. EJNMMI Research 10:1.
Crossref
Crossref
Claudia M. Salgado, Angelica Zin, Marta Garrido, Irina Kletskaya, Rita DeVito, Miguel Reyes-Múgica, Gianni Bisogno, Vittoria Donofrio & Rita Alaggio. (2020) Pediatric Soft Tissue Tumors With BCOR ITD Express EGFR but Not OLIG2. Pediatric and Developmental Pathology 23:6, pages 424-430.
Crossref
Crossref
Ramesh Duwa, Asmita Banstola, Fakhrossadat Emami, Jee-Heon Jeong, Sooyeun Lee & Simmyung Yook. (2020) Cetuximab conjugated temozolomide-loaded poly (lactic-co-glycolic acid) nanoparticles for targeted nanomedicine in EGFR overexpressing cancer cells. Journal of Drug Delivery Science and Technology 60, pages 101928.
Crossref
Crossref
Precious Barnes, F. A. Yeboah, Jinling Zhu, Roland Osei Saahene, Christian Obirikorang, Michael Buenor Adinortey, Benjamin Amoani, Foster Kyei, Patrick Akakpo & Yaw Asante Awuku. (2020) Prognostic Worth of Epidermal Growth Factor Receptor (EGFR) in Patients with Head and Neck Tumors. Journal of Cancer Epidemiology 2020, pages 1-7.
Crossref
Crossref
Gloria C. Chiang, David J. Pisapia, Benjamin Liechty, Rajiv Magge, Rohan Ramakrishna, Jonathan Knisely, Theodore H. Schwartz, Howard A. Fine & Ilhami Kovanlikaya. (2020) The Prognostic Value of MRI Subventricular Zone Involvement and Tumor Genetics in Lower Grade Gliomas. Journal of Neuroimaging 30:6, pages 901-909.
Crossref
Crossref
Fei‐Ting Hsu, Wei‐Ting Chen, Ching‐Te Wu & Jing‐Gung Chung. (2020)
Hyperforin induces apoptosis through extrinsic/intrinsic pathways and inhibits
EGFR
/
ERK
/
NF‐κB
‐mediated anti‐apoptotic potential in glioblastoma
. Environmental Toxicology 35:10, pages 1058-1069.
Crossref
Crossref
Nalin Leelatian, Justine Sinnaeve, Akshitkumar M Mistry, Sierra M Barone, Asa A Brockman, Kirsten E Diggins, Allison R Greenplate, Kyle D Weaver, Reid C Thompson, Lola B Chambless, Bret C Mobley, Rebecca A Ihrie & Jonathan M Irish. (2020) Unsupervised machine learning reveals risk stratifying glioblastoma tumor cells. eLife 9.
Crossref
Crossref
Aarushi Sharma & Randolph C. Elble. (2020) From Orai to E-Cadherin: Subversion of Calcium Trafficking in Cancer to Drive Proliferation, Anoikis-Resistance, and Metastasis. Biomedicines 8:6, pages 169.
Crossref
Crossref
Ji Zhang, Meige Guan, Qianliang Wang, Jiajun Zhang, Tianshou Zhou & Xiaoqiang Sun. (2020) Single-cell transcriptome-based multilayer network biomarker for predicting prognosis and therapeutic response of gliomas. Briefings in Bioinformatics 21:3, pages 1080-1097.
Crossref
Crossref
María González-Tablas, Daniel Arandia, María Jara-Acevedo, Álvaro Otero, Ana-Luisa Vital, Carlos Prieto, Nerea González-Garcia, Ana Belén Nieto-Librero, Herminio Tao, Daniel Pascual, Laura Ruiz, Pablo Sousa, Purificación Galindo-Villardón, Alberto Orfao & María Dolores Tabernero. (2020) Heterogeneous EGFR, CDK4, MDM4, and PDGFRA Gene Expression Profiles in Primary GBM: No Association with Patient Survival. Cancers 12:1, pages 231.
Crossref
Crossref
Sirui Ma, Soumon Rudra, Jian L Campian, Sonika Dahiya, Gavin P Dunn, Tanner Johanns, Michael Goldstein, Albert H Kim & Jiayi Huang. (2020) Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma. Neuro-Oncology Advances 2:1.
Crossref
Crossref
Haijing Liu, Bo Zhang & Zhifu Sun. (2020) Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan‐cancer analysis. Cancer Communications 40:1, pages 43-59.
Crossref
Crossref
Xiaoqiang Sun, Xiaoping Liu, Mengxue Xia, Yongzhao Shao & Xiaohua Douglas Zhang. (2019) Multicellular gene network analysis identifies a macrophage-related gene signature predictive of therapeutic response and prognosis of gliomas. Journal of Translational Medicine 17:1.
Crossref
Crossref
Chengkun Ye, Bomin Pan, Haoyue Xu, Zongren Zhao, Jiawei Shen, Jun Lu, Rutong Yu & Hongmei Liu. (2019) Co-delivery of GOLPH3 siRNA and gefitinib by cationic lipid-PLGA nanoparticles improves EGFR-targeted therapy for glioma. Journal of Molecular Medicine 97:11, pages 1575-1588.
Crossref
Crossref
Olivia G. Taylor, Joshua S. Brzozowski & Kathryn A. Skelding. (2019) Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets. Frontiers in Oncology 9.
Crossref
Crossref
Qiongna Dong, Bizhi Shi, Min Zhou, Huiping Gao, Xiaoying Luo, Zonghai Li & Hua Jiang. (2019) Growth suppression of colorectal cancer expressing S492R EGFR by monoclonal antibody CH12. Frontiers of Medicine 13:1, pages 83-93.
Crossref
Crossref
Wei-Zhen Gao, Lie-Mei Guo, Tian-Qi Xu, Yu-Hua Yin & Feng Jia. (2018) Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients. Journal of Translational Medicine 16:1.
Crossref
Crossref
Elisa Aquilanti, Julie Miller, Sandro Santagata, Daniel P Cahill & Priscilla K Brastianos. (2018) Updates in prognostic markers for gliomas. Neuro-Oncology 20:suppl_7, pages vii17-vii26.
Crossref
Crossref